Cantharidin Induces Apoptosis of Human Triple Negative Breast Cancer Cells through Mir-607-Mediated Downregulation of EGFR

Researchers studied the therapeutic potential of cantharidin for TNBC treatment by targeting epidermal growth factor receptor (EGFR), and expound its novel regulator miR-607.